Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti‐PD ‐1 based immunotherapy in hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and
anti‐PD
‐1 based immunotherapy in hepatocellular carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-05-18
DOI
10.1002/ijc.34118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
- (2021) Jumin Huang et al. GUT
- Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients
- (2021) Li Yuan et al. Frontiers in Microbiology
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
- (2021) Yotsawat Pomyen et al. Scientific Reports
- Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
- (2020) Lin Shui et al. Frontiers in Immunology
- Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
- (2020) Ligong Lu et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer
- (2020) Luigi Mandrich et al. Nutrients
- Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients
- (2020) Peng Song et al. Thoracic Cancer
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- Taxonomic diversity of sputum microbiome in lung cancer patients and its relationship with chromosomal aberrations in blood lymphocytes
- (2020) V. G. Druzhinin et al. Scientific Reports
- Probiotics for cancer alternative prevention and treatment
- (2020) Tesfaye Legesse Bedada et al. BIOMEDICINE & PHARMACOTHERAPY
- Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (RESCUE): a non-randomized, open-label, phase 2 trial
- (2020) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging
- (2020) Domonica N. Powell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity
- (2020) Karla A Lee et al. Journal for ImmunoTherapy of Cancer
- Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
- (2020) Angelo Limeta et al. JCI Insight
- The neuroactive potential of the human gut microbiota in quality of life and depression
- (2019) Mireia Valles-Colomer et al. Nature Microbiology
- A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
- (2019) Cyrielle Caussy et al. Nature Communications
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) A Vogel et al. ANNALS OF ONCOLOGY
- Identifying Gut Microbiota Associated With Colorectal Cancer Using a Zero-Inflated Lognormal Model
- (2019) Dongmei Ai et al. Frontiers in Microbiology
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
- (2019) Brandilyn A. Peters et al. Genome Medicine
- Stochastic processes shape microeukaryotic community assembly in a subtropical river across wet and dry seasons
- (2019) Weidong Chen et al. Microbiome
- A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
- (2018) Ping Luo et al. HEPATOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome
- (2016) J. M. Pitt et al. CANCER RESEARCH
- Analysis of the effect of dietary protected organic acid blend on lactating sows and their piglets
- (2016) Subramaniam Mohana Devi et al. REVISTA BRASILEIRA DE ZOOTECNIA-BRAZILIAN JOURNAL OF ANIMAL SCIENCE
- Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
- (2015) Robert R. Jenq et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- 3-Methylindole is Mutagenic and a Possible Pulmonary Carcinogen
- (2009) Jessica M. Weems et al. TOXICOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now